Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Participants With Chronic Hepatitis C Virus Infection Without Cirrhosis

NCT02114177 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

310

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C Virus Infection

Interventions

DRUG: Simeprevir
DRUG: Simeprevir
DRUG: Sofosbuvir
DRUG: Sofosbuvir

Sponsor

Janssen Infectious Diseases BVBA